EP1280931A4 - Dosage de fonction plaquettaire et reactif concu a cet effet - Google Patents

Dosage de fonction plaquettaire et reactif concu a cet effet

Info

Publication number
EP1280931A4
EP1280931A4 EP01934872A EP01934872A EP1280931A4 EP 1280931 A4 EP1280931 A4 EP 1280931A4 EP 01934872 A EP01934872 A EP 01934872A EP 01934872 A EP01934872 A EP 01934872A EP 1280931 A4 EP1280931 A4 EP 1280931A4
Authority
EP
European Patent Office
Prior art keywords
platelet function
function assay
reagent therefor
therefor
reagent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01934872A
Other languages
German (de)
English (en)
Other versions
EP1280931A2 (fr
Inventor
Donald E Mahan
Michael W Stewart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PharmaNetics Inc
Original Assignee
PharmaNetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PharmaNetics Inc filed Critical PharmaNetics Inc
Publication of EP1280931A2 publication Critical patent/EP1280931A2/fr
Publication of EP1280931A4 publication Critical patent/EP1280931A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326—Magnetic particles
    • G01N33/54333—Modification of conditions of immunological binding reaction, e.g. use of more than one type of particle, use of chemical agents to improve binding, choice of incubation time or application of magnetic field during binding reaction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP01934872A 2000-05-09 2001-05-09 Dosage de fonction plaquettaire et reactif concu a cet effet Withdrawn EP1280931A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20263800P 2000-05-09 2000-05-09
US202638P 2000-05-09
PCT/US2001/011760 WO2001086248A2 (fr) 2000-05-09 2001-05-09 Dosage de fonction plaquettaire et reactif concu a cet effet

Publications (2)

Publication Number Publication Date
EP1280931A2 EP1280931A2 (fr) 2003-02-05
EP1280931A4 true EP1280931A4 (fr) 2005-02-09

Family

ID=22750704

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01934872A Withdrawn EP1280931A4 (fr) 2000-05-09 2001-05-09 Dosage de fonction plaquettaire et reactif concu a cet effet

Country Status (9)

Country Link
EP (1) EP1280931A4 (fr)
JP (1) JP2003532891A (fr)
KR (1) KR20030014219A (fr)
AU (1) AU2001261020A1 (fr)
BR (1) BR0110735A (fr)
CA (1) CA2408850A1 (fr)
MX (1) MXPA02011017A (fr)
NO (1) NO20025300L (fr)
WO (1) WO2001086248A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6680177B2 (en) * 2001-12-07 2004-01-20 Cardiovascular Diagnostics, Inc. Low molecular weight heparin assay, system and reagent therefor
JP4078247B2 (ja) 2003-05-02 2008-04-23 キヤノン株式会社 磁性体−生体物質複合体型構造体、磁性体に対して結合能を有するアミノ酸配列を有するペプチド断片及びその遺伝子、ならびに磁性体−生体物質複合体型構造体の製造方法
US20120021010A1 (en) * 2010-04-29 2012-01-26 University Of Calcutta Antiplatelet agent and methods of using the same
KR101276179B1 (ko) * 2011-08-08 2013-06-18 고려대학교 산학협력단 혈소판 복합기능 검사 장치 및 방법, 이에 구비되는 미세교반칩
US8772040B2 (en) 2012-08-31 2014-07-08 Korea University Research And Business Foundation Apparatus and method of platelet multi-function analysis, and micro stirring chip

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5110727A (en) * 1987-04-03 1992-05-05 Cardiovascular Diagnostics, Inc. Method for performing coagulation assays accurately, rapidly and simply, using dry chemical reagents and paramagnetic particles
US5601991A (en) * 1993-02-17 1997-02-11 Cardiovascular Diagnostics, Inc. Dry chemistry cascade immunoassay and affinity assay
US5922551A (en) * 1997-03-20 1999-07-13 Accumetrics, Inc. Agglutrimetric platelet binding assays in blood
US5952184A (en) * 1992-12-03 1999-09-14 Alberta Cancer Board Methods for determining platelet function

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4849340A (en) * 1987-04-03 1989-07-18 Cardiovascular Diagnostics, Inc. Reaction system element and method for performing prothrombin time assay
TW221493B (fr) * 1990-07-10 1994-03-01 Cardiovascular Diagnostics Inc
US5616311A (en) * 1991-01-15 1997-04-01 Hemosphere, Inc. Non-crosslinked protein particles for therapeutic and diagnostic use
US5446132A (en) * 1992-10-01 1995-08-29 The General Hospital Corporation Thrombin-activated platelet protein-2 (TAPP-2)
US5686597A (en) * 1995-06-06 1997-11-11 Incyte Pharmaceuticals, Inc. Thrombin receptor homolog
US6046051A (en) * 1997-06-27 2000-04-04 Hemosense, Inc. Method and device for measuring blood coagulation or lysis by viscosity changes
US5932445A (en) * 1997-11-07 1999-08-03 Incyte Pharmaceuticals, Inc. Signal peptide-containing proteins

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5110727A (en) * 1987-04-03 1992-05-05 Cardiovascular Diagnostics, Inc. Method for performing coagulation assays accurately, rapidly and simply, using dry chemical reagents and paramagnetic particles
US5952184A (en) * 1992-12-03 1999-09-14 Alberta Cancer Board Methods for determining platelet function
US5601991A (en) * 1993-02-17 1997-02-11 Cardiovascular Diagnostics, Inc. Dry chemistry cascade immunoassay and affinity assay
US5922551A (en) * 1997-03-20 1999-07-13 Accumetrics, Inc. Agglutrimetric platelet binding assays in blood

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
OBERHARDT B J ET AL: "DRY REAGENT TECHNOLOGY FOR RAPID, CONVENIENT MEASUREMENTS OF BLOOD COAGULATION AND FIBRINOLYSIS", CLINICAL CHEMISTRY, AMERICAN ASSOCIATION FOR CLINICAL CHEMISTRY. WINSTON, US, vol. 37, no. 4, 1 April 1991 (1991-04-01), pages 520 - 526, XP000371778, ISSN: 0009-9147 *
YOKO MINAMOTO ET AL: "DETECTION OF PLATELET ADHESION/AGGREGATION TO IMMOBILIZED LIGANDS ON MICROBEADS BY AN AGGREGOMETER", THROMBOSIS AND HAEMOSTASIS, STUTTGART, DE, vol. 76, no. 6, 1996, pages 1072 - 1079, XP002921232, ISSN: 0340-6245 *

Also Published As

Publication number Publication date
WO2001086248A3 (fr) 2002-02-28
CA2408850A1 (fr) 2001-11-15
NO20025300D0 (no) 2002-11-05
WO2001086248A2 (fr) 2001-11-15
AU2001261020A1 (en) 2001-11-20
MXPA02011017A (es) 2004-08-19
JP2003532891A (ja) 2003-11-05
KR20030014219A (ko) 2003-02-15
EP1280931A2 (fr) 2003-02-05
BR0110735A (pt) 2007-05-08
NO20025300L (no) 2003-01-07

Similar Documents

Publication Publication Date Title
MXPA03004287A (es) Ensayo de interaccion de trombocitos/leucocitos y reactivo para el mismo.
GB9808145D0 (en) Assay
EP1255852A4 (fr) Reactif de dosage immunologique et de diagnostic pour le paludisme
GB9909793D0 (en) Improved assay and reagents therefor
GB0012860D0 (en) Assay
EP1280931A4 (fr) Dosage de fonction plaquettaire et reactif concu a cet effet
IL150948A0 (en) Detection reagent
GB0003069D0 (en) Improved assay
GB0008784D0 (en) Assay
GB0023057D0 (en) Liquid reagent
GB9809160D0 (en) Assay
GB9803156D0 (en) Assay
GB0005894D0 (en) Assay
GB0003902D0 (en) Assay
GB9910499D0 (en) Assay reagent
GB0014838D0 (en) An assay
GB0005895D0 (en) Novel assay
GB0010960D0 (en) Assay
GB9811845D0 (en) Assay reagent
GB0001703D0 (en) Assay
GB0025804D0 (en) Assay
GB0019242D0 (en) Assay
GB0013561D0 (en) Assay
GB0003898D0 (en) Assay
GB0023239D0 (en) Assay

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20021107

AK Designated contracting states

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

A4 Supplementary search report drawn up and despatched

Effective date: 20041228

RIC1 Information provided on ipc code assigned before grant

Ipc: 7G 01N 33/86 B

Ipc: 7G 01N 33/80 B

Ipc: 7C 12Q 1/56 A

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20041102